// App-Quantinova.ai

: Delayed interval scanning is not associated with stage-shift at diagnosis: Preliminary results to support guidelines for lung cancer screening during the COVID-19 pandemic

Researchers

Presenter

  • Andrew Creamer

Principal Investigators

  • Jennifer Dickson

  • Carolyn Horst

  • Sophie Tisi

  • Helen Hall

  • Priyam Verghese

  • John Mccabe

  • Kylie Gyertson

  • Anne-Marie Mullin

  • Laura Farrelly

  • Christina Clark

  • Stephanie Hamilton

  • Brian Allen

  • Allan Hackshaw

  • Anand Devaraj

  • Arjun Nair

  • Sam Janes

Medical Centers

  • Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom

  • Cancer Trials Centre, University College London, London, United Kingdom

  • Kings College London, London, United Kingdom

  • Lungs for Living, University College London, London, United Kingdom

  • GRAIL Inc, Menlo Park, United States of America

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Coronavirus disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved